Peri-Implant Tissues & the Mucosal Seal

Every implant that succeeds does so behind a soft-tissue seal — a cuff of mucosa that walls off the underlying bone and osseointegrated surface from the contaminated oral environment. That seal resembles the gingiva around a natural tooth and is often described in the same vocabulary, but it is not the same tissue, and the differences are the whole point of this chapter. The peri-implant mucosa has a keratinized outer surface and a sulcus, an epithelial barrier that attaches to titanium by hemidesmosomes, and a band of connective tissue above the bone crest. What it lacks — a periodontal ligament, cementum, and the perpendicular fiber insertion and rich dual blood supply they bring — is precisely what makes the implant seal more fragile.¹

The classic histometric account comes from Berglundh and Lindhe, who showed in a controlled canine model that the mucosa re-forms a relatively constant supracrestal dimension — a biologic width of roughly 3–4 mm — regardless of the starting tissue height.¹ That total comprises approximately 2 mm of junctional (barrier) epithelium and approximately 1.3–1.8 mm of supracrestal connective tissue. Cochran and colleagues confirmed an analogous, stable dimension around titanium implants and tied it to the position of the implant–abutment interface.² The clinically decisive feature lives in that connective-tissue band: where a tooth anchors collagen fibers perpendicularly into cementum, the implant offers no cementum, so its fibers run parallel to the surface and merely adhere. The tissue is also fibroblast-poor, collagen-rich, and scar-like, and — lacking the periodontal-ligament vascular plexus — it is fed only by supraperiosteal vessels, leaving it less vascular than gingiva. The downstream consequences are deeper probing and a greater susceptibility to peri-implant disease.³

Read from the mouth downward, the peri-implant seal is layered. The coronal-most lining is the sulcular epithelium — thin, non-keratinized, unattached — bounding the sulcus where the probe and biofilm sit. Apical to it is the junctional (barrier) epithelium, the principal epithelial seal, attaching to titanium through hemidesmosomes and a basal lamina and measuring approximately 2 mm in height.¹ Below the epithelium lies the supracrestal connective tissue, a band of roughly 1.3–1.8 mm whose collagen runs parallel to the implant surface. Together the epithelial and connective-tissue components constitute the biologic width.

Beneath and around all of this is the vascular bed. Around a tooth, the marginal tissue is supplied both by supraperiosteal vessels and by the periodontal-ligament plexus; at an implant the ligament — and therefore its plexus — is absent, so the tissue depends on supraperiosteal vessels alone. The result is measurably lower vascularity, reduced immune surveillance, and slower healing, which is why the same bacterial challenge is more dangerous at an implant than at a tooth.³

The figure makes the central contrast visible: at the tooth, fibers fan perpendicularly into cementum and a probe is arrested at the attachment; at the implant, fibers parallel the surface and a probe slides closer to the crest.

The seven features below summarize how the mucosal seal at an implant departs from the gingival attachment at a tooth. Each row carries an evidence grade: dimensional and structural claims rest on controlled histometric studies and systematic syntheses, while a handful of inferences about defense and disease behavior are drawn more cautiously from consensus interpretation.

Because a minimum supracrestal dimension re-forms regardless of the tissue it starts with, soft-tissue height is not a passive bystander — it is a determinant of crestal bone behavior. Where mucosa is thin (≤2 mm) at the time of abutment connection, healing characteristically includes crestal bone resorption to create the vertical space the seal requires.¹ This is the biological argument for thickening thin tissue before or at placement, for thoughtful interface positioning, and for restraint in disturbing the seal once formed. The grafting decision itself is developed in its own chapter (see Soft-Tissue Grafting Algorithm →).

The same weak-seal biology explains why peri-implant inflammation, once established, can advance toward bone more readily than gingival inflammation at a tooth: parallel fibers and reduced vascularity offer the bacterial front a less-resistant apical path and a less-competent defense.³ Surveillance, maintenance, and the staged management of established disease are therefore inseparable from the anatomy described here (see Supportive Peri-Implant Care → and Peri-Implant Disease Management →).